Why is Metropolis Healt falling/rising?

As of 10-Jul, Metropolis Healthcare Ltd is experiencing a decline in its stock price, currently at Rs 1,974.55, which reflects a decrease of Rs 83.75 or 4.07%. Today's performance indicates that the stock has underperformed its sector by 3.07%, following a trend reversal after eight consecutive days of gains. The stock reached an intraday low of Rs 1,948.75, marking a drop of 5.32%. Over the past week, the stock has shown a return of 13.88%, significantly outperforming the Sensex, which remained nearly flat at -0.06%. However, despite these short-term gains, the stock has a year-to-date return of -4.30%, indicating challenges in maintaining upward momentum. Positive factors include high management efficiency with a return on capital employed (ROCE) of 26.87% and low debt-to-equity ratio, but these are overshadowed by poor long-term growth metrics, such as a mere 9.22% annual growth in net sales over the last five years and disappointing recent financial results.
In the broader market context, while Metropolis Healthcare's short-term performance has been strong relative to the benchmark, its year-to-date performance lags behind the Sensex, which has gained 6.46%. The stock's recent decline can be attributed to negative financial results, including a significant drop in profit before tax and profit after tax compared to previous quarters, alongside an expensive valuation with a price-to-book ratio of 7.7. Although institutional holdings are high at 45.58%, indicating confidence from larger investors, the overall sentiment is tempered by the company's inability to demonstrate consistent long-term growth, leading to a cautious outlook among investors.